[1]
F. Marotta, “A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome”, Acta Biomed, vol. 84, no. 1, pp. 53–60, Jun. 2013, Accessed: May 02, 2026. [Online]. Available: https://mail.mattioli1885journals.com/index.php/actabiomedica/article/view/2429